Literature DB >> 33533096

Synthesis of Glycodendrimers with Antiviral and Antibacterial Activity.

Pilar Hoyos1, Almudena Perona1, Olga Juanes2, Ángel Rumbero2, María J Hernáiz1.   

Abstract

Glycodendrimers are an important class of synthetic macromolecules that can be used to mimic many structural and functional features of cell-surface glycoconjugates. Their carbohydrate moieties perform key important functions in bacterial and viral infections, often regulated by carbohydrate-protein interactions. Several studies have shown that the molecular structure, valency and spatial organisation of carbohydrate epitopes in glycoconjugates are key factors in the specificity and avidity of carbohydrate-protein interactions. Choosing the right glycodendrimers almost always helps to interfere with such interactions and blocks bacterial or viral adhesion and entry into host cells as an effective strategy to inhibit bacterial or viral infections. Herein, the state of the art in the design and synthesis of glycodendrimers employed for the development of anti-adhesion therapy against bacterial and viral infections is described.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  anti-infection agents; antiadhesion therapy; carbohydrate-protein interactions; glycodendrimers; macromolecules

Year:  2021        PMID: 33533096     DOI: 10.1002/chem.202005065

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

Review 1.  Structural Considerations for Building Synthetic Glycoconjugates as Inhibitors for Pseudomonas aeruginosa Lectins.

Authors:  Karolina Wojtczak; Joseph P Byrne
Journal:  ChemMedChem       Date:  2022-05-03       Impact factor: 3.540

Review 2.  Biocatalyzed Synthesis of Glycostructures with Anti-infective Activity.

Authors:  Pilar Hoyos; Almudena Perona; Teodora Bavaro; Francesca Berini; Flavia Marinelli; Marco Terreni; María J Hernáiz
Journal:  Acc Chem Res       Date:  2022-08-09       Impact factor: 24.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.